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 1. INTRODUCTION 
The word diabetes was coined by Aretaeus (81–133 CE). The word 
is taken from Greek diabainein, which means “passing through.” because 
of one of its main symptom is excessive urine production. In 1675, Thomas 
Willis noted that a diabetic’s urine and blood has a sweet taste and 
added mellitus to the name (Greek mel means “honey”) In 1776, it was 
confirmed that the sweet taste was because of an excess of sugar in the 
urine and blood. 
Diabetes mellitus is a metabolic disorder of multiple etiology 
characterized by chronic hyperglycaemia with disturbance of 
carbohydrate, fat and protein metabolism resulting from defects in insulin 
secretion, insulin action or a to a combination of both (Deutschlander et 
al., 2009). It affected about 171 million people worldwide in 2000 and the 
number is projected to increase to at least 366 million by 2030 (Ali et al., 
2006). 
One therapeutic approach for treating diabetes is to decrease the 
post-prandial hyperglycaemia. This is done by retarding the absorption of 
glucose through the inhibition of the carbohydrate-hydrolyzing enzymes, 
α-amylase and α-glucosidase, in the digestive tract. Inhibitors of these 
enzymes delay carbohydrate digestion and prolong overall carbohydrate 
digestion time, causing a reduction in the rate of glucose absorption and 
consequently blunting the post-prandial plasma glucose rise (Rhabasa-
Lhoret and Chiasson et al,, 2004). Examples of such inhibitors which are in 
clinical use are acarbose, miglitol and voglibose (Bailey et al., 2003). Plants 
continue to play an important role in the treatment of diabetes, 
particularly in developing countries where most people have limited 
resources and do not have an access to modern treatment. The increase 
in demand in industrially-developed countries to use alternative 
approaches to treat diabetes, such as plant-based medicines, is also due 
to the side effects associated with the use of insulin and oral 
hypoglycaemic agents (Marles and Farnsworth, 1994). These authors 
identified species from 725 genera, 183 families of plants, and another 
review identified more than 800 plant species as potential treatments for 
diabetes mellitus (Perez et al., 1998). In another recent review, (Grover et 
al., 2002) stated that more than 1123 plant species have been used 
ethnopharmacologically or experimentally to treat symptoms of diabetes. 
There are more than 200 pure compounds from plant sources that have 
been reported to show blood glucose lowering activity (Ali et al., 2006). 
TYPES OF DIABETES MELLITUS 
Diabetes sufferers fall into two broad categories – those with type 1 
diabetes (formerly known as "juvenile" or "childhood" diabetes) and those 
with type 2 (or adult) diabetes. There is also said to be a third form of 
diabetes known as type 3 or gestational diabetes but, despite the fact 
that there are a few differences, this is basically nothing more than type 2 
diabetes which occurs during, and because of, pregnancy. 
In type 1 diabetes sufferers develop a problem with the insulin 
producing beta-cells of the pancreas and are unable to produce 
sufficient insulin to transfer glucose from the bloodstream to the cells of the 
body. This means that it is necessary to closely monitor levels in the blood 
and to administer insulin so that glucose can be transferred and the 
glucose levels in the blood returned to normal. 
In type 1 diabetes the beta cell destruction is caused by the free 
radicals of oxygen generated by cytotoxic T lymphocytes and 
macrophages.  
Symptoms of type 1 diabetes includes increased blood sugar, 
excessive thirst, frequent urination, increased appetite, weight loss, poor 
wound healing and blurred vision. 
In type 2 diabetes the body usually continues to produce insulin 
normally but the body's cells develop a resistant to it and insulin levels 
begin to increase in the blood. In type 2 diabetes, insulin resistance 
includes decreased stimulation of muscle glycogen synthesis and 
hexokinase activity. It is believed that most subjects developing type 2 
diabetes pass through a phase of impaired glucose tolerance (Yoshikawa 
et al., 2009). 
Symptoms of type 2 diabetes include polydipsia, polyphagia, 
polyuria, weight loss, dry mouth, itchy skin, fatigue, impotence, recurrent 
infections etc (Frier and Fischer, 2006). 
Gestational diabetes is a form of diabetes which affects pregnant 
women. It is believed that the hormones produced during pregnancy 
reduce a woman's receptivity to insulin, leading to high blood sugar levels. 
MECHANISMS OF BLOOD SUGAR REGULATION 
Blood sugar levels are regulated by negative feedback in order to 
keep the body in homeostasis. The levels of glucose in the blood are 
monitored by the cells in the pancreas Islets of Langerhans. If the blood 
glucose level falls to dangerous levels (as in very heavy exercise or lack of 
food for extended periods), the Alpha cells of the pancreas release 
glucagon, a hormone whose effects on liver cells act to increase blood 
glucose levels. They convert glycogen into glucose (this process is called 
glycogenolysis). The glucose is released into the bloodstream, increasing 
blood sugar levels. 
There are also several other causes for an increase in blood sugar 
levels. Among them are the 'stress' hormones such as adrenaline, several 
of the steroids, infections, trauma, and of course, the ingestion of food. 
When levels of blood sugar rise, whether as a result of glycogen 
conversion, or from digestion of a meal, a different hormone is released 
from beta cells found in the Islets of Langerhans in the pancreas. This 
hormone, insulin, causes the liver to convert more glucose into glycogen 
(this process is called glycogenesis), and to force about 2/3 of body cells 
(primarily muscle and fat tissue cells) to take up glucose from the blood, 
thus decreasing blood sugar. Insulin also provides signals to several other 
body systems, and is the chief regulatory metabolic control in humans. 
Diabetes mellitus type 1 is caused by insufficient or non-existent 
production of insulin, while type 2 is primarily due to a decreased response 
to insulin in the tissues of the body (insulin resistance). Both types of 
diabetes, if untreated, result in too much glucose remaining in the blood 
(hyperglycemia) and many of the same complications. Also, too much 
insulin and/or exercise without enough corresponding food intake in 
diabetics can result in low blood sugar (hypoglycemia). 
ROLE OF INSULIN 
Insulin secretion has been 
through the following process. 
Glucose enters B cells by GLUT 2 
transporters. It is phosphorylated and 
metabolized to pyruvate (Pyr) in the 
cytoplasm. Pyruvate enters 
mitochondria and is metabolized via 
citric acid cycle. The ATP formed by 
oxidative phosphorylation inhibits ATP-
sensitive K+ channels, reducing K+ efflux. This depolarises the B cell, and 
Ca2+ influx is increased. The Ca2+ stimulates release of insulin by exocytosis. 
Glutamate (Glu) is also formed and this primes secretory granules 
preparing them for exocytosis (Ganong, 2003). 
The discovery of insulin is appropriately attributed to Banting and 
Best. Insulin consists of two peptide chains (A and B, of 21 and 30 amino 
acid residues, respectively) with two disulphide linkages. Insulin is required 
for the glucose to enter into the cells. Insulin is a hormone secreted by the 
Islets of Langerhans in pancreas and its main role is to transport the 
glucose from the blood to the different cells of the body. If the pancreas 
doesn’t produce sufficient amount of insulin or the produced insulin does 
not work properly, the glucose can’t enter into the body cells and hence 
glucose stays in the blood and cause high blood sugar level leading to 
diabetes. Hence body loses its main source of fuel for energy; even though 
blood contains a huge amount of glucose. The high level blood glucose 
for a longer period causes many complications to different systems of the 
body. Insulin is a member of a family of related peptides termed insulin-like 
growth factors (IGFs). IGFs are produced in many tissues, and they may 
serve a more important function in the regulation of growth than in the 
regulation of metabolism (Frier and Fisher, 2006). 
ENZYMES INVOLVED IN CARBOHYDRATE METABOLISM 
Glucose and fructose can be transported out in the intestinal lumen 
into the blood stream after hydrolysis of the glucosidic bonds in digestable 
food containing starch. Complex starches must be broken down into 
individual monosaccharides before being into the duodenum and the 
upper part of the jejunum. The digestion is facilitated by enteric enzymes, 
including α-amylase and α- glucosidases that are attached to the brush 
border of the intestinal cells (Ortiz-Andrade et al., 2006). 
ALPHA GLUCOSIDASE INHIBITORS (AGIs) 
α-glucosidase and α-amylase are the key enzymes involved in the 
metabolism of carbohydrates. α-amylase degrades complex dietary 
carbohydrates to oligosaccharides and disaccharides, which are 
ultimately converted into monosaccharides by α-glucosidases. Liberated 
glucose is then absorbed by the gut and results in postprandial 
hyperglycaemia. Inhibition of intestinal α-glucosidases limit postprandial 
glucose levels by delaying the process of carbohydrate hydrolysis and 
absorption, making such inhibitors useful in the management of type 2 
diabetes (Shinde et al., 2008). 
AGIs are among the available glucose-lowering medications. The 
α-glucosidase (systematic name: α-D-glucoside glucohydrolase) is an 
enzyme of the intestinal brush border that hydrolyses terminal, 
nonreducing 1,4-linked α-D-glucose residues and releases α-D-glucose. 
Inhibition of α-glucosidase diminishes glucose resorption and postprandial 
hyperglyacemia. While α-glucosidase catalyses the exohydrolysis of 
oligosaccharides, a related enzyme α-amylase (systematic name: 1,4-α-D-
glucan glucanohydrolase) catalyses the endohydrolysis of 1,4- α-D-
glucosidic linkages in polysaccharides with 3 or more 1,4- α-linked D-
glucose units (Schafer et al., 2006). The AGIs delay, but do not prevent, the 
absorption of ingested carbohydrates, reducing the postprandial glucose 
and insulin peaks (Andrade-Cetto et al., 2007). 
AGIs like acarbose and miglitol are competitive inhibitors of 
intestinal α-glucosidases and reduces the postprandial digestion and 
absorption of starch and disaccharides (Ortiz-Andrade et al., 2006). AGIs 
slow down the digestion and absorption of dietary carbohydrates either 
by means of dietary manipulation or by intestinal α-glucosidase inhibitory 
drugs like acarbose, Voglibose or Miglitol. These drugs have shown promise 
in reducing postprandial hyperglycaemia, hyperinsulinemia and burden of 
postprandial oxidative stress (Rao et al., 2009). Furthermore, AGIs also offer 
other benefits like, reducing triglyceride levels and postprandial insulin 
levels. Targeting postprandial hyperglycemia may further provide 
advantages as it has been linked to cardiovascular mortality (Babu et al., 
2004). 
 
 
ALPHA AMYLASE INHIBITORS (AAIs) 
Starch is a polymer of glucose (polysaccharide) that is relatively 
insoluble. There are many enzymes in the human digestive system that 
help in the digestion of food (Rang et al., 1999). α-amylase catalyses the 
breakdown of starch to maltose and finally to glucose, which is the only 
sugar that can be utilized by the body. (Kotowaroo et al., 2005) 
α-amylase (systematic name: 1,4-α-D-glucan glucanohydrolase) 
catalyses the endohydrolysis of 1,4- α-D-glucosidic linkages in 
polysaccharides with 3 or more 1,4- α-linked D-glucose units (Schafer et al., 
2006). 
AAIs play a major role in managing postprandial hyperglycaemia in 
diabetic patients. These drugs inhibit the action of the amylase enzyme 
leading to the reduction of the starch hydrolysis, which shows beneficial 
effects on glycaemic index. The known glucosidase inhibitors used in 
managing diabetes are acarbose and miglitol competitively and 
reversibly inhibits α- glucosidase enzyme from intestine as well as pancreas, 
but both of these drugs has the side effects such as abdominal pain, 
flatulence and diarrhoea. Hence there is the necessity of a natural enzyme 
inhibitor with high potential without any side effects (Bhat et al., 2008). 
ROLE OF FREE RADICALS IN DIABETES MELLITUS 
The major cause of diabetes is oxidative stress induced 
hyperglycaemia which leads to reactive oxygen species (ROS) formation 
from a oxidative phosphorylation, glucose auto-oxidation, NAD(P)H 
oxidase, lipooxygenase, cytochrome P450 monooxygenase and nitric 
oxide synthase. Besides ROS, there are reactive nitrogen species (RNS) 
which causes nitrosative stress on diabetes patients; and also xanthine 
oxidase (XO) is proposed to be the major source of reactive oxygen 
species (ROS). ROS and RNS production depletes enzymatic and 
nonenzymatic antioxidants causing cellular damage to the more 
susceptible tissues like kidney, liver and and erythrocytes (Valko et al., 
2006). Glucose auto-oxidation in hyperglycaemia generates ROS, which 
causes chronic oxidative stress, thereby depleting the antioxidant defense 
system. It also leads to an overdrive of electron transport chain, resulting in 
the overproduction of superoxide anions which are scavenged normally 
by mitochondrial superoxide dismutase. (Rachchh et al., 2008) 
Diabetic hyperglycaemia causes a variety of pathological changes 
in small vessels, arteries and peripheral nerves. Vascular endothelial cells 
become partially vulnerable targets of hyperglycaemic damage as 
glucose continuously flows through them. Hyperglycaemia increases the 
production of reactive oxygen species (ROS) inside the aortic endothelial 
cells and oxidative stress acts as a contributing factor in the pathogenesis 
of diabetes. Diabetes increases the production of tissue damaging 
reactive oxygen species (ROS) by glucose auto-oxidation and 
nonenzymatic protein glycosylation. (Tiwari & Rao, 2002) 
For the normal functioning of the beta cells of the pancreas active 
oxygen metabolism is required. Long term exposure of pancreatic β cells 
to high glucose levels can cause β cell dysfunction, while the consequent 
production of ROS potentially suppresses the insulin gene promoter their by 
impairing the insulin synthesis and its secretion. Oxidative stress is not itself a 
disease but a condition that can lead to or accelerate disease. Oxidative 
stress occurs when the available supply of the body's antioxidants is 
insufficient to handle and neutralize free radicals of different types. The 
result is massive cell damage that can result in cellular mutations, tissue 
breakdown and immune compromise. Free radicals are formed from the 
molecules through the breakage of the chemical bonds and by collision 
of the non radical species by a reaction between a radical and a 
molecule. Free radicals react with DNA bases enhancing base alterations 
causing mutations and DNA rearrangements (Aruoma et al., 2007). 
 
 
Fig. 2: Pathways of carbohydrate metabolism and targets where 
imbalance leads to hyperglycaemia and resultant diabetic syndrome 
(Tiwari & Rao, 2002) 
 
 
Fig. 3 Single unifying mechanism of oxidative stress due to persistent 
hyperglycaemia, which leads to overt generation of ROS in mitochondria 
(Tiwari & Rao, 2002) 
 
ROLE OF ANTIOXIDANTS DEFENSE SYSTEM 
Antioxidants are substances when present at lower concentrations 
compared with those of an oxidisable substrate significantly delays or 
prevents oxidation of the substrate. The harmful effect of free radicals 
causing potential biological damage is called as oxidative stress and 
nitrosative stress. This occurs in biological system when there is imbalance 
in physiological homeostasis i.e. ROS/RNS over production and deficiency 
to enzymatic and nonenzymatic antioxidants. The balance between 
harmful and beneficial effects of free radical in living organisms is 
maintained by "redox regulation" which protects various oxidative stresses 
and maintains redox homeostasis. Pathogenesis of various 
neurodegenerative disorders, cancer, ischemia / reperfusion injury, 
inflammatory diseases and ageing are due to the involvement of cellular 
oxidants The human body has several mechanisms to counteract the 
oxidative stress by producing antioxidants, which are either naturally 
produced or externally supplied through foods. Endogeneous and 
exogeneous antioxidants act as free radical scavengers by preventing 
and repairing the damages caused by the ROS and RNS (Huy et al, 2008). 
Use of antioxidants provides therapeutic benefits in diabetes related 
endothelial dysfunction as well as oxidative damage to the pancreatic 
cells (Gokce and Haznedaroglu, 2008). 
ETHNOBOTANICAL HERBS 
During the past decade, traditional systems of medicine have 
become a topic of global importance. Current estimates suggest that, in 
many developing countries, a large proportion of the population relies 
heavily on traditional practitioners and medicinal plants to meet primary 
health care needs. Although modern medicine may be available in the 
developing countries, herbal medicines (phytomedicines) have often 
maintained popularity for historical and cultural reasons. Concurrently 
many people in developed countries have begun to turn to alternative or 
complementary therapies, including medicinal herbs.  
Most of the drugs which are now available are expensive and also 
precipitate adverse effects such as hypoglycaemia, obesity, etc. Diabetes 
management without any toxic side effect is a challenge in diabetic 
research. So there exists a need for a thorough research on more effective 
and safer hypoglycaemic agents. Investigations on antidiabetic agents 
derived from medicinal plants have gained momentum, as 
recommended by WHO for research on medicinal plants containing 
hypoglycaemic activity (Sharma et al., 2007). Numerous medicinal plants 
have been reported in the folkloric history worldwide for the treatment of 
diabetes. Traditional ethno botanicals provide novel leads to diabetic 
research due to rapidly increasing interest in finding newer medicines with 
better efficacy and safety. Research is carried out in traditional herbs to 
prove its described activity with the focus on evidence based traditional 
medicine (Verpoorte, 2007). 
The plants are capable of synthesizing various secondary 
metabolites with varied antioxidant potential which can probably afford 
protection against the molecular damage induced by ROS. Various 
indigenous medicinal plants have been used in the treatment of diabetes 
from time immemorial and WHO Expert committee 1980 has also 
recommended attention towards plants in investigating the traditional 
methods of diabetes mellitus. (Sridevi et al., 2008) 
Our country is proud to have a rich and varied source of traditional 
medicine and it is each one of our researchers judicious mind that should 
be prepared to study the potential of this knowledge in the chain of drug 
discovery process. Our country also has a rich herbal and medicinal plant 
wealth with suitable geographical climatic conditions and has well 
documented practical knowledge for the traditional herbal medicines 
(Grover et al., 2002). Belief in the curative powers of the plants rested 
exclusively upon the traditional knowledge i.e, empirical information not 
subjected to critical examination. 
Herbal alternatives are proven to provide symptomatic relief and 
assist in the prevention of secondary complications. Few herbs are also 
proven to help in the regeneration of the beta cells improving insulin 
resistance. Herbal alternatives are necessary due to the inabilities of the 
current therapies to sustain normoglycaemia and prevent diabetic 
complications. Due to the enormous costs of the modern medicine rural 
populations in the developing countries still rely upon the traditional 
medicines as their primary health care; moreover herbs have the cultural 
acceptability among them. 
PHYTOCHEMICALS IN THE MANAGEMENT OF DIABETES 
The side effects from prolonged administration of conventional 
drugs have necessitated the search for safe and effective alternatives. 
Also, it has been observed that certain resistant cases of diabetes that do 
not respond well to conventional drugs often responds well after 
supplementation with natural remedies. 
Many plant extracts and isolated phytochemicals have been 
examined for antidiabetic activity. Medicinal plants and herbs are of great 
importance to the health of individuals and communities. The World Health 
Organization (WHO) estimates that currently 80% of the world’s population 
uses the botanical medicine for their primary healthcare needs. (Sharma 
et al.,2007). Despite the existence of herbal medicines over many 
centuries, only relatively small number of plant species has been studied 
for their application. However, in the recent past, an increasing research 
evidence is getting accumulated, which clearly indicate the positive role 
of traditional medicinal plants in the prevention or control of some 
metabolic disorders like diabetes. The great advantage of these medicinal 
plants is that these are easily available and have no side effects.  
Now the reputation of the herbal medicines is growing globally 
wider, even though their active compounds are unknown, which is only 
due to its therapeutic efficacy and safety (Hakkim et al., 2007). 
Mechanisms of action of most of the indigenous medicinal plants are still 
unknown and most of the antioxidant herbs have a significant role in the 
management of diabetes and most of the antidiabetic herbs are reported 
for its antioxidant activity also. 
Herbal remedy, the ancient healing system from India has steadily 
increased its popularity in the western countries. The botanicals in the 
Ayurvedic Materia Medica have been proven to be safe and effective, 
through several hundreds to thousands years of its use. This proves the 
positive role of traditional medicinal plants in the prevention or control of 
some metabolic disorders like diabetes, heart disease and certain types of 
cancer. The great advantages of these medicinal plants are easily 
availability and lesser or no side effects (Majeed and Prakash, 2007). 
Herbal preparation alone or in combination with other hypoglycaemic 
agents may produce a good therapeutic response in certain resistant 
individuals were allopathic treatment fails (Ghosh, 2004). Traditional herbs 
can be supplemented in the dietary management of diabetic patients 
along with certain non pharmacological measures such as diet, exercise & 
weight loss (Gayathri and Kannabiran 2008). 
  
 
 
 
 
 
 
 
 
PLANT PROFILE 
Plant name        :      Benincasa hispida (Thunb) Cogn. 
Family        : Cucurbitaceae. 
Synonym  : Benincasa ceriferae.  
 
Vernacular names 
English  : Ash gourd, White gourd melon 
Tamil  : Pusanikkai.  
Malayalam  : Kum palam. 
Telugu : Budidagummadi. 
Kannada : Budikumbala. 
Hindi  : Petha, Raksa.  
Sanskrit : Kusamandah. 
 
Biological Source: : Fresh juice and dried seeds of Benincasa 
hispida 
                                                (Thunb) Cogn. 
 Part Used                        : Fruits and seeds. 
 
Distribution 
Cultivated throughout India in plains and hills.  
 
 
 
Description 
A large trailing gourd climbing by means of tendrils. Leaves large, 
hispid beneath. Flowers yellow, unisexual, male peduncle 7.5 – 10 cm 
long, female peduncle shorter. Fruits broadly cylindrical, 30 – 45 cm long, 
hairy throughout, ultimately covered with a waxy bloom. Seeds consists of 
hard hull, thin internal seed coat and cotyledon (Krithikar K.R. and Basu 
R.D. 1988). 
 
Medicinal uses 
The fruits are sweet, cooling, styptic, laxative, diuretic, tonic, 
aphrodisiac and antiperiodic. They are useful in asthma, cough, diabetes, 
haemoptysis, hemorrhages from internal organs, epilepsy, fever and 
vitiated conditions of pitta. The seeds are cooling and anthelmintic and 
are useful in dry cough, fever, urethrorrhea, syphilis, hyperdipsia and 
vitiated conditions of pitta (Krithikar K.R. and Basu, R.D. 1988). 
 
 
 
 
 
 
Fig. 4: Benincasa hispida (Thunb) Cogn. Fruit and Seeds 
  
  
 
 
 
 
 
 
 
 
 
2. REVIEW OF LITERATURE 
Bhalodia et al., (2009) suggested that reactive oxygen species play 
a role in the pathophysiology of renal ischemia/reperfusion (I/R) injury. This 
study was designed to investigate renoprotective activity of methanolic 
fruit extract of Benincasa cerifera in I/R induced kidney failure in rats. 
Renal I/R caused significant impairment of kidney function. Six-day 
administration of Benincasa cerifera minimized this effect. Rats with renal 
I/R showed significantly decreased activity of superoxide dismutase, 
catalase, and reduced glutathione compared with sham operated rats. 
These declining trends were significantly less in the group treated with 
Benincasa cerifera compared with those in the I/R only group. Renal I/R 
produced a significant increase in malondialdehyde level, while 
pretreatment with Benincasa cerifera was associated with a significantly 
lower malondialdehyde level (P <0.001). These findings imply that ROS play 
a crucial role in I/R-induced kidney injury and Benincasa cerifera exerts 
renoprotective activity probably by the radical scavenging activity. 
Rachchh et al., (2008) investigated antiulcer activity of Benincasa 
hispida (Thunb.) Cogn. fruit extract in rats against ethanol-induced gastric 
mucosal damage, pylorus ligated (PL) gastric ulcers, and cold restraint-
stress (CRS)-induced gastric ulcer models. Petroleum ether and methanol 
extracts were administered orally at 300 mg/kg and omeprazole at the 
dose of 20 mg/kg. Ulcer index was the common parameter studied in all 
the models. Vascular permeability was evaluated in ethanol model, effect 
on lipid peroxidation, viz. malondialdehyde content, superoxide dismutase 
and catalase levels were studied in CRS model. Both extracts produced 
significant reduction in ulcer index (P < 0.05) in all the models. Significant 
reduction in vascular permeability (P <0.05) was observed. In CRS model 
malondialdehyde content was significantly reduced along with increase 
in catalase levels as compared to control groups which confirms that 
petroleum ether and methanol extracts of Benincasa hispida possess 
significant antiulcer activity as well as antioxidant property. 
Moon et al., (2008) investigated the mechanism of anti-vascular 
inflammatory activity of an aqueous extract of Benincasa hispida (ABH) in 
human umbilical vein endothelial cells (HUVECs). The study was performed 
on HUVECs that were pretreated with various concentrations (1-20 µg/ml) 
of ABH before exposure with high glucose (25 mM) for 48 h. Cell ELISA and 
Western blot analysis showed that ABH reduced cell adhesion of U937 
monocytes. ABH also inhibited the mRNA expression level of monocyte 
chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8). High glucose 
induced ROS production was inhibited by treatment of ABH. It was 
observed that pretreatment with HUVECs with ABH blocks NF-κB activation 
via blocking phosphorylation and degreadation of its inhibitory protein I 
κB-α. ABH also reduced NF-κB promoter activity. These results suggested 
that ABH reduces high glucose-induced CAMs activation by inhibiting 
monocyte adhesion, ROS, and NF-κB in HUVECs. 
Mathad et al., (2005) suggested that the methanolic extract of fruit 
extract of Benincasa hispida (BHFE) was evaluated for its antidiarrheal 
potential against several experimental models of diarrhea in rats. BHFE 
treated animals showed significant inhibitory activity against castor oil 
induced diarrhea and inhibited PGE2 induced enter pooling in rats. It also 
showed significant reduction in gastrointestinal motility following charcoal 
meal in rats. The results confirmed the efficacy of BHFE as an antidiarrheal 
agent. 
Huang et al., (2004) investigated the abilities of antioxidation and 
inhibition of angiotensin-converting enzyme (ACE) activity of Benincasa 
hispida pulp, core, seed and peel prepared by different extraction 
methods. The fresh weights required to reach 50% inhibition of linoleic acid 
oxidation were higher in fresh extracts compared to other extraction 
methods. Fresh weights required to reach 50% inhibition were the lowest in 
seed. The seed had the lowest Cu2+ -induced low-density lipoprotein (LDL) 
oxidation percentage and inhibition level of ACE activity among all parts. 
The higher antioxidant capacity of the seed may result from the higher 
total phenolic contents and superoxide dismutase activity. The abilities of 
antioxidation and ACE activity inhibition may provide protective effects 
against cardiovascular diseases and cancers. 
Kumar et al., (2004) investigated the anorectic effect of the 
methanolic extract of Benincasa hispida (MEBH) in Swiss albino mice. 
Fasted mice were administered with various doses of MEBH (0.2-1 
g/kg,i.p.), and the food intake was measured hourly for a period of 7 h. In 
another experiment, the percentage of gastric emptying at 4th h was 
determined after the administration of MEBH (0.2-1 g/kg, i.p.) in different 
set of mice which had free access to preweighed food for either 1, 2 or 4 
h. MEBH significantly reduced the cumulative food intake over a 7 h 
period in a dose-dependent manner. The percentage reduction of 
cumulative food intake at 7th h for MEBH with 0.2, 0.6 and 1 g/kg was 27%, 
38% and 54% respectively. The 4 h gastric emptying was not significantly 
influenced by MEBH when compared to control. The present study reveals 
for the first time a possible anorectic activity of Benincasa hispida, most 
probably mediated through the CNS without affecting the gastric 
emptying. However, further studies are required to find its potential as an 
antiobesity agent. 
Kumar et al., (2002) studied methanolic extract of Benincasa 
hispida (MEBH) showed excellent protection in guinea pigs against the 
histamine-induced bronchospasm even at a very low dose, 50 mg/kg, 
p.o. However, even at higher dose level 400 mg/kg, MEBH did not offer 
any significant protection against acetylcholine challenge. Therefore, it 
can be deduced that MEBH is unlikely to have muscarinic action. Thus, the 
results suggest that the protective effect against bronchospasm induced 
by histamine aerosol may be mediated by antihistaminic activity (H1 
receptor antagonism). 
Grover et al., (2001) investigated antiulcerogenic activity of 
different extracts of Benincasa hispida (fresh juice, supernatant and 
residue fraction of centrifuged juice, alcoholic and petroleum ether 
extract). These were studied in aspirin plus restraint, swimming stress, 
indomethacin plus histamine and serotonin-induced ulcers in rats and 
mice. The oral feeding of different doses of the extract significantly 
reduced the ulcer index produced by various ulcerogens. The anti-
ulcerogenic effect was dose-dependent in stress induced model of ulcer 
and not in other models. Benincasa hispida probably has a CNS 
component in prevention of stress induced ulceration. However, 
antihistaminic, anticholinergic effects and prevention of disturbance in 
gastric micro-circulation as possible modes of action cannot be ruled out. 
Thus extracts of Benincasa hispida may be considered to be a drug of 
natural origin possessing anti-ulcer activity. 
Deutschländer et al., (2009) investigated four plants for 
hypoglycemic activity by evaluating inhibiting effects on carbohydrate-
hydrolyzing enzymes: α-glucosidase and α-amylase. Acetone plant 
extracts were screened against C2C12 myocytes, 3T3-L1 preadipocytes 
and Chang liver cells by measuring glucose uptake. Cytotoxicity was 
done in preadipocytes and hepatocytes. Extract of Euclea undulata root 
bark exhibited highest activity, displaying a glucose uptake of 162.2% by 
Chang liver cells at 50mg/ml. An inhibition concentration of 50% for 
Euclea undulata was found to be 49.95 mg/ml for α-glucosidase and 2.8 
mg/ml for α-amylase. No cytotoxicity was recorded for Euclea undulata, 
while Schkuhria pinnata and Elaeo dendron transvaalense exhibited 
cytotoxicity at 2.5mg/ml. α-Glucosidase and α-amylase assays showed 
inhibitory activity on enzymes for three plant extracts. Euclea undulata, 
Schkuhria pinnata and Elaeo dendron transvaalense showed in vitro 
hypoglycemic activity. Schkuhria pinnata and Elaeo dendron 
transvaalense indicated cytotoxicity on 3T3-L1 preadipocytes and Chang 
liver cells. Euclea undulata, Pteronia divaricata and Elaeodendron 
transvaalense inhibited α-glucosidase and α-amylase enzymes. Screening 
of plant extracts scientifically validated traditional use of Euclea undulata 
for treatment of diabetes. Cytotoxicity results revealed that acetone 
extracts of Schkuhria pinnata and Elaeo dendron transvaalense are toxic 
and raise concern for chronic use. 
Subramanian et al., (2008) worked on in vitro α-glucosidase and α-
amylase enzyme inhibitory effects of Andrographis paniculata extract and 
andrographolide. The extract showed appreciable α-glucosidase 
inhibitory effect in a concentration-dependent manner and a weak α-
amylase inhibitory activity. Andrographolide demonstrated a similar α-
glucosidase and α-amylase inhibitory activity. The positive in vitro enzyme 
inhibition tests paved way for confirmatory in vivo studies. The in vivo 
studies demonstrated that A. paniculata extract significantly (P<0.05) 
reduced peak blood glucose and area under curve in diabetic rats when 
challenged with oral administration of starch and sucrose. Further, 
andrographolide also caused a significant (P<0.05) reduction in peak 
blood glucose and area under the curve in diabetic rats. Hence α-
glucosidase inhibition may possibly be one of the mechanisms for the A. 
paniculata extract to exert antidiabetic activity and indicates that AP 
extract can be considered as a potential candidate for the management 
of type 2 diabetes mellitus. 
Rao et al., (2009) investigated antihyperglycemic activity of root 
extracts of Derris indica which resulted in isolation and characterization of 
two new furanoflavanoids (1, 2) along with thirteen known compounds (3–
15). Their structures were determined on the basis of extensive 
spectroscopic (IR, MS, 1D and 2D NMR) data analysis and by comparison 
with the literature data. All the compounds were tested in vitro for 
intestinal α-glucosidase inhibitory and DPPH radical activity. New 
compounds (1, 2) displayed moderate intestinal α-glucosidase inhibitory 
as well as free radical scavenging activity. Other compounds also 
displayed varying degrees of moderate intestinal α-glucosidase inhibitory 
activity. Pongamol (6) displayed potent intestinal α-glucosidase inhibition. 
Yoshikawa et al., (2009) found α-glucosidase inhibitory (α-GI) effect 
of metal ions and their complexes which showed the high blood glucose 
lowering effect in diabetic model animals. The Cu(II) ion and its complexes 
showed strong α-GI activity greater than clinically used acarbose in in 
vitro studies. Furthermore, in in vivo experiments, α-GI action was newly 
discovered in normal ddy mice. These results suggested that one of action 
mechanisms of the antidiabetic metal ions and complexes is related to 
the α-GI effects. 
Shinde, et al., (2008) evaluated Syzygiumcumini seed kernel 
extracts for the inhibition of α-glucosidase from mammalian (rat intestine), 
bacterial (Bacillus stearothermophilus), and yeast (Saccharomyces 
cerevisiae, baker’s yeast). In vitro studies using the mammalian α-
glucosidase from rat intestine showed the extracts to be more effective in 
inhibiting maltase when compared to the acarbose control. Since 
acarbose is inactive against both the bacterial and the yeast enzymes, 
the extracts were compared to 1-deoxynojirimycin. We found all extracts 
to be more potent against α-glucosidase derived from B. 
stearothermophilus than that against the enzymes from either baker’s 
yeast or rat intestine. In an in vivo study using Goto–Kakizaki (GK) rats, the 
acetone extract was found to be a potent inhibitor of α-glucosidase 
hydrolysis of maltose when compared to untreated control animals. 
Therefore, these results point to the inhibition of α-glucosidase as a 
possible mechanism by which this herb acts as an antidiabetic agent. 
Andrade-Cetto et al., (2007), tested the butanolic extracts of four 
Mexican plants with respect to their α-glucosidase inhibition activity, 
without excluding other possible mechanisms of action. The plants 
Cecropia obtusifolia Bertol., Equisetum myriochaetum Schlecht Cham, 
Acosmium panamense (Benth.) Yacolev and Malmea depressa (Baill) R.E. 
Fries are used in traditional medicine to treat type 2 diabetes. In previous 
studies, we have demonstrated these plants hypoglycemic activity and 
determined the phytochemical composition of their extracts. The results in 
n-STZ diabetic rats loaded with maltose showed that Malmea and 
Acosmium extracts decreased plasma glucose significantly from 30 min 
on resembling the effect of acarbose. Cecropia extract produced the 
highest reduction of plasma glucose, and at 90 min, the glucose level was 
lower than the fasting level, which suggests another mechanism of action. 
Equisetum did not exert any effect. In vitro assays of α-glucosidase activity 
showed an IC50 of 14 mg/ml for Cecropia, 21 mg/ml for Malmea, and 109 
mg/ml for Acosmium, which were lower than that of acarbose (128 
mg/ml). Equisetum did not show any significant effect on this assay, either. 
These results contribute to understand the mechanism of action of these 
plants on glucose metabolism. 
Ortiz-Andrade et al., (2006), investigated α-glucosidase inhibitory 
activity of Tournefortia hartwegiana (METh) and established one of the 
possible modes of action of METh to induce antidiabetic activity. METh 
(310 mg/kg) effect on α-glucosidase activity was investigated. METh 
intragastric administration was conducted to determine oral glucose 
tolerance test (OGTT), using different substrates: glucose, sucrose and 
maltose. The increase in plasma glucose level was significantly suppressed 
(P < 0.05) by the extract after substrates administration. On the other 
hand, METh inhibited α-glucosidase activity in vitro, in a concentration 
dependent manner (IC50 of 3.16 mg/mL). These results suggest that METh 
might exert its antidiabetic effect by suppressing carbohydrate absorption 
from intestine and thereby reducing the post-prandial increase of blood 
glucose. 
Schäfer et al., (2006) found out that the standardized maritime pine 
bark extract (Pycnogenol) was reported to exert clinical antidiabetic 
effects after peroral intake. However, an increased insulin secretion was 
not observed after administration of the extract to patients. The aim was 
to elucidate whether the described clinical effects of Pycnogenol are 
related to inhibition of α-glucosidase. Therefore, the inhibitory activity of 
Pycnogenol, green tea extract and acarbose towards α-glucosidase was 
analyzed. Furthermore, he explored different fractions of Pycnogenol 
containing compounds of diverse molecular masses from polyphenolic 
monomers, dimers and higher oligomers to uncover which components 
exhibited the most pronounced inhibitory activity and found that 
Pycnogenol exhibited the most potent inhibition (IC50 about 5 μg/mL) on 
α-glucosidase compared to green tea extract (IC50 about 20 μg/mL) and 
acarbose (IC50 about 1 mg/mL). The inhibitory action of Pycnogenol was 
stronger in extract fractions containing higher procyanidin oligomers. The 
results obtained assign a novel, local effect to oligomeric procyanidins 
and contribute to the explanation of glucose-lowering effects of 
Pycnogenol observed in clinical trials with diabetic patients. 
Babu et al., (2004) reported that methanolic extract of rhizome of 
Himalayan rhubarb Rheum emodi displayed mild yeast as well as 
mammalian intestinal α-glucosidase inhibitory activity. However, further 
fractionation of active extract led to the isolation of several potent 
molecules in excellent yields, displaying varying degrees of inhibition on 
two test models of α-glucosidase. Rhapontigenin, desoxyrhapontigenin, 
chrysophanol-8-O–β-d-glucopyranoside, torachrysone-8-O-β-d-
glucopyranoside displayed potent yeast α-glucosidase inhibition. 
However, chrysophanol-8-O–β-d-glucopyranoside, desoxyrhaponticin and 
torachrysone-8-O–β-d-glucopyranoside displayed potent to moderate 
mammalian α-glucosidase inhibitory activity. Other compounds displayed 
mild activity on both the tests. Except desoxyrhapontigenin and 
rhapontigenin that increased Vmax, other compounds including crude 
extract decreased the Vmax significantly (p<0.02) in yeast α-glucosidase 
test. Further kinetic analysis on mammalian α-glucosidase inhibition 
showed that chrysophanol-8-O–β-d-glucopyranoside, desoxyrhaponticin 
and  torachrysone-8-O-β-d-glucopyranoside may be classified as mixed-
noncompetitive inhibitors. However, desoxyrhapontigenin and 
rhapontigenin may be classified as modulators of enzyme activity. 
Presence and position of glycoside moiety in compounds appear 
important for better inhibition of mammalian α-glucosidase. This is the first 
report assigning particularly, mammalian intestinal α-glucosidase inhibitory 
activity to these compounds. Chrysophanol-8-O–β-d-glucopyranoside, 
desoxyrhaponticin, desoxyrhapontigenin and rhapontigenin have been 
isolated in substantial yields from R. emodi for the first time. Therefore, 
these compounds may have value in the treatment and prevention of 
hyperglycemia associated diabetes mellitus. 
Ali et al., (2006) studied extracts of six selected Malaysian plants 
with a reputation of usefulness in treating diabetes were examined for α-
amylase inhibition using an in vitro model. Inhibitory activity studied by two 
different protocols (with and without pre-incubation) showed that 
Phyllanthus amarus hexane extract had α-amylase inhibitory properties. 
Hexane and dichloromethane extracts of Anacardium occidentale, 
Lagerstroemia speciosa, Averrhoa bilimbi, Pithecellobium jiringa and 
Parkia speciosa were not active when tested without pre-incubation. 
Extraction and fractionation of Phyllanthus amarus hexane extract led to 
the isolation of dotriacontanyl docosanoate, triacontanol and a mixture 
of oleanolic acid and ursolic acid. Dotriacontanyl docosanoate and the 
mixture of oleanolic acid and ursolic acid are reported from this plant 
species for the first time. All compounds were tested in the α-amylase 
inhibition assay and the results revealed that the oleanolic acid and 
ursolic acid (2:1) mixture was a potent α-amylase inhibitor with IC50 = 2.01 
mg/ml (4.41mM) and that it contributes significantly to the α-amylase 
inhibition activity of the extract. Three pure pentacyclic triterpenoids, 
oleanolic acid, ursolic acid and lupeol were shown to inhibit α-amylase. 
Kotowaroo et al., (2005) investigated seven exotic/indigenous 
medicinal plants of Mauritius, namely Coix lacryma-jobi (Poaceae), Aegle 
marmelos (Rutaceae), Artocarpus heterophyllus (Moraceae), Vangueria 
madagascariensis (Rubiaceae), Azadirachta indica (Meliaceae), 
Eriobotrya japonica (Rosaceae) and Syzigium cumini (Myrtaceae) for 
possible effects on starch breakdown by alpha-amylase in vitro. The results 
showed that only Artocarpus heterophyllus significantly (p < 0.05) inhibited 
alpha-amylase activity in vitro. To confirm the observed effects, a further 
biochemical assay was undertaken to investigate the effects of 
Artocarpus heterophyllus on alpha-amylase activity using rat plasma in 
vitro. It was found that the aqueous leaf extract significantly (p < 0.05) 
inhibited alpha-amylase activity in rat plasma. The highest inhibitory 
activity (27.20 +/- 5.00%) was observed at a concentration of 1000 μg/mL. 
However, in both cases dose dependency was not observed. Enzyme 
kinetic studies using the Michaelis-Menten and Lineweaver-Burk equations 
were performed to establish the type of inhibition involved. In the 
presence of the plant extract the maximal velocity (Vmax) remained 
constant (1/150 g / L/s) whereas the Michaelis-Menten constant (Km) 
increased by 5.79 g/L, indicating that the aqueous leaf extract of 
Artocarpus heterophyllus behaved as a competitive inhibitor. Results from 
the present study tend to indicate that Artocarpus heterophyllus could act 
as a 'starch blocker' thereby reducing post-prandial glucose peaks. 
Hubert et al., (2005) reported novel acaricidal compounds with 
inhibitory effects on the digestive enzymes of arthropods are a safe 
alternative to the traditional neurotoxic pesticides used for control of the 
stored-product pests. He explored the properties of acarbose, the low 
molecular weight inhibitor of α--amylases (AI), as a novel acaricide 
candidate for protection of the stored products from infestation by Acarus 
siro (Acari: Acaridae). In vitro analysis revealed that AI blocked efficiently 
the enzymatic activity of digestive amylases of A. siro and decreased the 
physiological capacity of mite's gut in utilizing a starch component of 
grain flour. In vivo experiments showed that AI suppressed the population 
growth of A. siro. The mites were kept for three weeks on experimental diet 
enriched by AI in concentration range of 0.005 to 0.25%. Population 
growth of A. siro was negatively correlated with the content of AI in the 
treated diet with a half-population dose of 0.125%. 
Tormo et al., (2004) investigated alpha-amylase inhibitory activity of 
extract of white kidney beans (Phaseolus vulgaris). The acute oral 
administration of the inhibitor (50 mg/kg body weight) to adult Wistar rats 
together with a starch load (2 g/kg body weight suspended in NaCl (9 
g/l)) reduced the increase in glycaemia ov0065r the basal value (NaCl, 
222 (SEM 49); inhibitor, 145 (SEM 16) mmol/l £ 180 min; P,0·05) without 
modifying the insulin response. On administering the inhibitor orally (50 
mg/kg body weight dissolved in NaCl (9 g/l)) for 21 d to rats fed on a 
standard diet, a decline was observed in the glycaemia values on day 0 
(NaCl, 5·53 (SEM 0·12); inhibitor, 5·25 (SEM 0·16) mmol/l) relative to those 
obtained on days 10 (NaCl, 5·00 (SEM 0·14); inhibitor, 4·60 (SEM 0·08) 
mmol/l; P,0·05) and 21 (NaCl, 5·22 (SEM 0·22); inhibitor, 4·50 (SEM 0·12) 
mmol/l; P,0·01) of treatment, without modifying the plasma concentration 
of insulin. There was found to be a significant anorexigenic action of the 
inhibitor; there was reduced food intake (NaCl,23·07 (SEM 0·31); inhibitor, 
19·50 (SEM 0·49) g/d; P,0·01), a reduced weight gain (NaCl, 52 (SEM 3); 
inhibitor, 21·33 (SEM 8·9) g/21 d; P,0·01), as well as changes in the activity 
of some intestinal enzymes such as maltase (NaCl, 87 (SEM 7); inhibitor, 127 
(SEM 11) U/g proteins; P,0·05). The present study has shown,for the first 
time, that the prolonged administration of an alpha-amylase inhibitor 
reduces blood glucose levels and body-weight gain in Wistar rats. 
 
Svensson et al., (2003) reported proteins that inhibit α-amylases 
have been isolated from plants and microorganisms. These inhibitors can 
have natural roles in the control of endogenous α-amylase activity or in 
defense against pathogens and pests; certain inhibitors are reported to 
be antinutritional factors. The α-amylase inhibitors belong to seven 
different protein structural families, most of which also contain 
evolutionary related proteins without inhibitory activity. Two families 
include bifunctional inhibitors acting both on α-amylases and proteases. 
High-resolution structures are available of target α-amylases in complex 
with inhibitors from five families. These structures indicate major diversity 
but also some similarity in the structural basis of α-amylase inhibition. 
Mutational analysis of the mechanism of inhibition was performed in a few 
cases and various protein engineering and biotechnological approaches 
have been outlined for exploitation of the inhibitory function. 
Umamaheswari et al., (2007) evaluated the antiulcer and 
antioxidant activities of ethanolic extract of leaves of Jasminum 
grandiflorum L (JGLE). Antiulcerogenic activities of  JGLE was evaluated 
employing aspirin + pylorus ligation (APL) and alcohol (AL) induced acute 
gastric ulcer models ulcer-healing activity using acetic acid-induced 
chronic ulcer model in rats. The antioxidant activity of JGLE has been 
assayed by using in vitro methods like DPPH assay, reductive ability, 
superoxide anion scavenging activity, nitric oxide scavenging activity and 
total phenolic content. The reduction in gastric fluid volume, total acidity 
and an increase in the pH of gastric fluid in APL rats proved the 
antisecretory activity of JGLE. These results suggest that leaves of 
Jasminum grandiflorum possess potential antiulcer activity, which may be 
attributed to its antioxidant mechanism of action.  
Velickovic et al., (2007) performed the extraction of flavonoids from 
garden (Salvia officinalis L.) and glutinous (Salvia glutinosa L.) sage by 
ultrasonic and classical maceration. In that study flavonoids were 
analysed in the extracts of garden (Salvia officinalis L.) and glutinous 
(Salvia glutinosa L.) sage. Ultrasonic extraction (20 minutes at 40°C) and 
classical maceration (6 h at room temperature) of the extractable 
substances from dried herbs and dried residual plant materials from which 
the essential oil had previously been removed by hydrodistillation were 
performed with petroleum ether, 70 % aqueous solution of ethanol and 
water. It was found that the extracts from both plants contained 
flavonoids, apigenin and its derivatives (e.g., apigenin 4'-methyl ether), 
scutellarein 6-methyl ether, isoscutellarein 8-methyl ether, luteolin and 6-
OH-luteolin-6-methyl ether where distinctive for S. officinalis. Apigenin, 
luteolin, 6-OH-luteolin-6-methyl ether, kaempherol 3-methyl ether, 
kaempherol 3,7-dimethylether, quercetin 3,7,3'-trimethyl ether and 
quercetin 3,7,3',4'-tetramethyl ether were distinctive for S. glutinosa. 
Hsu (2006) reported the antioxidant activities of Polygonum aviculare 
L extract for its free radical scavenging, superoxide radical scavenging, 
lipid peroxidation and hydroxyl radical induced DNA strand scission 
assays. All the methods employed in their study proved the antioxidant 
activity. 
Conforti et al., (2005) investigated the biological properties , 
antioxidant properties  and antidiabetic activity of two varieties of 
Amaranthus caudatus seeds, the phenolic contents, oil, squalene were 
determined. The IC50 values were determined for the various extracts and 
were found to be not significantly different from each other and α 
amylase inhibitory activity was found to be significant. 
Li et al., (2005) investigated the effect and action mechanism of a 
methanolic extract from the flowering part of Punica granatum Linn. 
(Punicaceae) (PGF) on hyperglycemia in vivo and in vitro. When orally 
administered, the PGF extract markedly lowered plasma glucose levels in 
non-fasted Zucker diabetic fatty rats (a genetic model of obesity and 
type 2 diabetes), whereas it had little effect in the fasted animals, 
suggesting it affected postprandial hyperglycemia in type 2 diabetes. Also 
the extract was found to markedly inhibit the increase of plasma glucose 
levels after sucrose loading, but not after glucose loading in mice, and it 
had no effect on glucose levels in normal mice. In vitro, PGF extract 
demonstrated a potent inhibitory effect on α glucosidase activity. The 
inhibition is dependent on the concentration of enzyme and substrate, as 
well as on the length of pretreatment with the enzyme. Hence PGF extract 
improves postprandial hyperglycemia in type 2 diabetes and obesity, at 
least in part, by inhibiting intestinal α glucosidase activity. 
Mensor et al., (2001) studied the Brazilian plant extracts belonging 
to 16 species of 5 different families. They were tested against the stable 
DPPH (2, 2-diphenyl-1-picryl-hydrazyl-hydrate) free-radical. The ability to 
scavenge DPPH radical was measured by the discoloration of the solution. 
Based on the results, they concluded that ethanol extracts of plants 
showed lower EC50 values than the other plant extracts. 
Gomes et al., (2001) tested two natural products Polypodium 
leucotomos extract (PL) and kojic acid (KA) for their ability to scavenge 
reactive oxygen species. Hydroxy radicals were generated by the Fenton 
reaction, and the rate constant of scavenging were 1.6x109 M-1s-1 for KA 
and 1.0x109 M-1 s-1 for PL, similar to that of ethanol (1.4x109 M-1 s-1). With 
superoxide anion generated by the xanthine/hypoxanthine system, KA 
and PL (0.2-1.0 mg/ml) inhibited ˙O2 dependent reduction of nitroblue 
tetrazolium by up to 30 and 31%, respectively. The present study 
demonstrates that PL showed an antioxidant effect, scavenging three of 
four reactive oxygen species tested. 
Guzman et al., (2001) studied the anti-inflammatory, analgesic and 
free radical scavenging activities of hydro soluble and liposoluble extracts 
of the marine microalgae Chlorella stigmatophora and Phaeodactylum 
tricornutum. The hydro soluble components of both species showed 
significant anti inflammatory, analgesic and free radical scavenging 
activity. These activities were not detected in the liposoluble fractions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. OBJECTIVE AND PLAN OF WORK 
Diabetes is probably the most common disease in this century. It 
has been estimated that over 150 million people worldwide have diabetes 
and that this will increase to 220 million by 2010 and 300 million by 2025 (Li 
et al., 2005). These metabolic disturbances result in acute and long term 
diabetic complications. Free radicals and oxidative stress may act as a 
common pathway to diabetes as well for later complications. The 
increased oxidative stress in diabetes includes the auto-oxidation of 
glucose and nonenzymatic glycation and also changes in antioxidant 
defense system. Though there are many synthetic drugs available for the 
treatment of diabetes they all have side effects associated with their uses. 
Herbal formulations are considered to be less toxic and more 
effective and also free from side effects than synthetic ones. Numerous 
plants are claimed to possess antidiabetic phytoconstituents in folk 
medicines; however, one among them is Benincasa hispida (Thunb) Cogn 
fruit and seed. Since there is no specific scientific report regarding its use 
as a hypoglycemic agent, the plant was selected for the study and from 
the literatures reviewed, it was found that the fruit and seeds have been 
reported for its mast cell stabilizing effect, diuretic, antiulcer (Rachchh et 
al., 2008) nootropic, antidepressant and nephroprotective activity against 
mercury poisoning in rats (Kumar et al., 2004). The seeds have a higher 
capacity on anti-oxidation and inhibition of angiotensin-converting 
enzyme (ACE) activity than the fresh fruit (Huang et al., 2004). It may be 
due to its high phenolic contents and superoxide dismutase activity 
(Rachchh et al., 2008). 
Review of literatures also urges that, the hypoglycemic activity of 
the fruit extract has to be evaluated as the plant tissue is constituted by 
secondary metabolites like flavonoids, terpenes, C-glycosides and sterols 
which have antioxidant effects (Bhalodia et al., 2009). Review of literatures 
for the seed extract confirms the presence of active saponins, urea, 
citrulline, linoleic acid, oleic acid and fatty acids. 
The main objective of the present study is to evaluate the 
hypoglycaemic activity of Benincasa hispida (Thunb). Cogn fruits and 
seeds using various in vitro models like α-amylase and α-glucosidase 
inhibitory effects and antioxidant activity. 
The scope of the present study is attributed in exploring the 
potential of the bioactive compounds from the medicinal plants and in 
revealing their safety & efficacy, there by realizing the promising ethno 
botanical herbs, towards the development of phytomedicine. 
PLAN OF WORK 
I. Collection, authentification, preparation & preliminary 
phytochemical screening of aqueous extracts of the fruit and seeds 
of Benincasa hispida (Thunb) Cogn. 
 
II. To evaluate the hypoglycaemic activity of Benincasa hispida (Thunb) 
Cogn using in vitro models such as, 
1. α glucosidase inhibition assay. 
2. α amylase inhibition assay. 
 
III. To evaluate the antioxidant activity of Benincasa hispida (Thunb) Cogn 
using in vitro models such as, 
1. DPPH radical scavenging assay (Hydrogen donating ability) 
2. Deoxy ribose degradation assay (Hydroxyl radical scavenging 
activity)  
3. NBT reduction assay (Superoxide radical scavenging activity)   
4. Reducing power ability 
 
IV.  Statistical analysis. 
 
V.   Writing up and submission of dissertation. 
 
 
 
 
4. MATERIALS AND METHODS 
 
4.1. DRUGS AND CHEMICALS  
Acarbose (Biocon Ltd), α-amylase & α-glucosidase (Sisco Research 
Laborotaries Ltd Mumbai), Glucose assay kits (Agappe diagnostics, 
Kerala), 2,2-diphenyl-1-picryl hydrazyl were purchased from HiMedia 
Laboratories, Mumbai, ascorbic acid, 2-deoxy-2-ribose, xanthine oxidase, 
quercetin, kaempferol, hesperidine, rutin, xanthine oxidase, hypoxanthine, 
pyrocatechol were purchased from Sisco Research Lab, Mumbai and 
butylated hydroxy toluene from Loba Cheme.  Thiobarbituric acid, 
trichloroacetic acid, and potato starch were purchased from SD Fine 
Chemicals Ltd. All other chemicals used in the study were of analytical 
grade purchased from respective suppliers. 
4.1.1. INSTRUMENTS USED 
Rotary Evaporator (Heidolph WB 2000, Mumbai), Cooling centrifuge 
(Remi Instruments, Chennai), Ultrasonic cleaner (Vibronics Ltd, Mumbai), 
Digital Balance (Sartorius Ltd., USA), Shimadzu-Jasco V-530 UV/Vis 
spectrophotometer, ELCO L1/27 pH meter. 
 
 
 4.2. PLANT MATERIAL 
4.2.1. Collection and authentication 
The fruits of Benincasa hispida (Thunb) Cogn. was collected from 
the local market during the month of June and July 2009. The plant 
specimen was identified and authenticated by Dr. G.V.S. Murthy, Joint 
Director, Botanical Survey of India, Coimbatore-3, Tamil Nadu and the 
specimen has been preserved in the institute Herbarium with voucher 
specimen code No. BSI/SC/5/23/09-10/Tech – 456 dated July 24, 2009. 
4.2.2. Preparation of the Benincasa hispida (Thunb) Fruit Extract 
Seeds were removed from the fruit and the fruit pulp is made into a 
juice. The pulp juice is evaporated at 70°C. The juice was reduced to 
gummy state and then it was dried in vacuum desiccators to obtain the 
Benincasa hispida (Thunb) Cogn. fruits powder (BHFP) and stored in an 
airtight container. 
4.2.3. Preparation of the Benincasa hispida (Thunb) Seed Extract 
The seeds were dried in shade and finely powdered. The powdered 
seeds were macerated with water and stirred continuously in a 
mechanical shaker for 4 hours. The preparation was kept aside for 24 h. It 
was again stirred in the mechanical shaker for 4 h and kept aside for 12 h. 
These contents were taken and filtered through a muslin cloth and the 
filtrate was distilled to get a dark gummy material. This is then dried, to 
obtain the Benincasa hispida (Thunb) Cogn. seed powder (BHSP) and 
stored in an airtight container. 
 
4.2.4. Preliminary phytochemical screening of Benincasa hispida fruit and 
seed powders (BHFP and BHSP) 
BHFP and BHSP were subjected to qualitative phytochemical tests 
to determine the presence of various phytoconstituents (Trease and 
Evans, 2002; Sanni et al., 2008) like tannins, phenolics, saponins, flavonoids, 
terpenoids, alkaloids, proteins and glycosides. 
a.   Test for tannins and phenolics 
To the solution of the extract, a few drops of 0.1% ferric chloride, 1% 
gelatin solution, 10% lead acetate was added and observed for 
brownish green or a blue-black color. 
b.   Test for saponins 
About 10 ml of the extract was mixed with 5 ml of distilled water 
and shaken vigorously for a stable persistent-froth. The frothing was 
mixed with 3 drops of olive oil and shaken vigorously and then 
observed for the formation of emulsion. When mixed with dilute 
sulphuric acid and boiled with 90% ethanol, if the initial frothing 
disappears it confirms the presence of higher concentration of 
saponins. 
c.   Test for flavonoids  
1. To a portion of the extract concentrated H2SO4 was added.  A 
yellow colouration indicates the presence of flavonoids.  The yellow 
colour disappears on standing.  
2. Few drops of 1% AlCl3 solution was added to a portion of extract. A 
yellow colouration indicates the presence of flavonoids. 
3. A portion of the extract was heated with 10 ml of ethyl acetate 
over a steam bath for 3 min.  The mixture was filtered and 4 ml of 
the filtrate was shaken with 1 ml of dilute ammonia solution.  A 
yellow colouration indicates a positive test for flavonoids.  
d.   Test for terpenoids 
About 5 ml of the extract was treated with 2 ml of chloroform and 
about 3 ml concentrated H2SO4 was carefully added to form a layer.  A 
reddish brown coloration of the interface indicates the presence of 
terpenoids. 
e.   Test for alkaloids  
A small portion of the extract was stirred with few drops of dil. HCl and 
filtered.  
1. To the filtrate, Dragendorff’s reagent (potassium bismuth iodide  
solution) was added and an orange brown precipitate indicates 
the presence of alkaloids.   
2. To the filtrate, Mayer’s reagent was added and a cream 
precipitate indicates the presence of alkaloids. 
f.   Test for proteins  
A portion of the extract was mixed with few drops of water and 
added Millon’s test and Biuret reagents. A yellowish brown precipitate 
indicates the presence of proteins. 
 
g.   Test for glycosides  
A portion of the extract was mixed with few drops of Fehling’s 
solution A & B and heated gently. A brick red precipitate indicates the 
presence of glycosides. 
4.3. IN VITRO HYPOGLYCAEMIC STUDIES 
Glucose can be readily absorbed from the G.I.T. by the presence of enzyme 
α-amylase and α-glucosidases. Inhibition of these enzymes reduces the 
postprandial blood glucose levels. Hence in vitro α-amylase & α-glucosidase 
inhibition models were carried out to screen BHFP and BHSP and evaluate its 
potential hypoglycaemic activity. 
4.3.1. Inhibition of α amylase in vitro 
PROCEDURE 
A 1% starch solution was prepared in 25 ml of 20 mM sodium 
phosphate buffer with 6.7 mM sodium chloride, pH 6.9 at 65°C for 15 
minutes. The α amylase enzyme was obtained from porcine pancreas and 
its solution was prepared by mixing 1 mg of α amylase in 250 ml of cold 
deionised water. The calorimetric reagent was prepared by mixing sodium 
potassium tartarate (12 g in 8 ml of 2 mM sodium hydroxide and 96 mM of 
3, 5-dinitrosalicylic acid solution. BHFP and BHSP extracts were dissolved in 
5% DMSO (Dimethylsulphoxide) to give a final concentration of 1 mg/ml. 
One ml of starch solution was mixed with 1 ml of increasing 
concentration of the BHFP and BHSP (100-1000 µg/ml) and mixed by 
swirling and equilibrated to 20°C. Then added one ml of α amylase 
solution and incubated at 20°C for 5 minutes to undergo the reaction with 
the starch. To the above solution add 1 ml of the colorimetric reagent 
solution and heated in a water bath for 15 minutes. The reduction of 3, 5-
dinitrosalicylic acid to 3-amino-5-nitrosalicylic acid corresponds to the 
maltose generation with the colour change from yellowish orange to wine 
red. Then it is cooled and added 9 ml of deionised water to make a final 
volume of 13 ml and then the absorbance was recorded at 540 nm for 
both test and blank using a suitable spectrophotometer (Sigma Aldrich, 
1997; Thalapaneni et al., 2008) 
Assay condition 
T = 37°C, pH = 6.9, A540nm,   Light path =1 cm, Calorimetric method 
Unit definition 
One unit will liberate 1mg of maltose from starch in 5 minutes at pH 
6.9 at 20°C and pH 6.9 under specified conditions.  
The α amylase inhibition was expressed as percentage of inhibition 
and the IC50 values determined by linear regression of plots with varying 
concentration of BHFP and BHSP against the percentage inhibition from 
three separate tests. 
4.3.2. Inhibition of α glucosidase in vitro 
α glucosidase enzyme obtained from yeast as lyophilised powder 
was used as the target protein source for the study of the enzyme 
inhibition using maltose as the substrate. Acarbose is used as positive 
control and the plant extract is prepared at the concentration of 1 mg/ml 
with 5% v/v DMSO (Dimethyl sulphoxide).The enzyme and the substrate 
were dissolved in 0.2 M Tris buffer at pH 8. 
PROCEDURE 
The enzymatic assay mixture consists of 1 ml of glucosidase enzyme 
(1U/ml), 1 ml of 37 mM of maltose substrate, 1 ml each of BHFP and BHSP & 
acarbose at varying concentration (10µg - 100µg) in 5% v/v DMSO 
(Dimethyl sulphoxide) which is incubated at 37ºC for 30 min. After 
incubating for 30 min, 0.2 ml of the assay mixture is mixed with 1 ml of the 
kit reagent. Glucose released in the assay mixture is quantified with 
commercial glucose oxidase assay kit (GOD-POD Kit, Agappe 
Diagnostics, Kerala). The enzymatic activity was measured by the amount 
of glucose released, which was detected spectrophotometrically at 505 
nm. The rate of carbohydrate breakdown was determined by calculating 
the amount of glucose obtained when carbohydrate was completely 
digested. The enzyme inhibitory activity was determined as the 
percentage inhibition and the assays were carried out in triplicate & the 
rate of prevention was calculated. The IC50 of the BHFP and BHSP required 
to inhibit the activity of the enzyme by 50% was determined by linear 
regression of the plots with varying concentration of BHFP and BHSP Vs 
percentage inhibition from the three separate tests (Subramanian et al., 
2008; Thalapaneni et al., 2008) 
Assay condition 
T = 37°C, pH = 6.9, A540nm,   Light path =1 cm, Calorimetric method 
Unit definition 
One unit will liberate 1mg of maltose from starch in 5 minutes at pH 
6.9 at 20°C and pH 6.9 under specified conditions.  
The α amylase inhibition was expressed as percentage of inhibition 
and the IC50 values determined by linear regression of plots with varying 
concentration of BHFP and BHSP against the percentage inhibition from 
three separate tests. 
4.4.2. Inhibition of α glucosidase in vitro 
α glucosidase enzyme obtained from yeast as lyophilised powder 
was used as the target protein source for the study of the enzyme 
inhibition using maltose as the substrate. Acarbose is used as positive 
control and the plant extract is prepared at the concentration of 1 mg/ml 
with 5% v/v DMSO (Dimethyl sulphoxide).The enzyme and the substrate 
were dissolved in 0.2 M Tris buffer at pH 8. 
PROCEDURE 
The enzymatic assay mixture consists of 1 ml of glucosidase enzyme 
(1U/ml), 1 ml of 37 mM of maltose substrate, 1 ml each of BHFP and BHSP & 
acarbose at varying concentration (10µg - 100µg) in 5% v/v DMSO 
(Dimethyl sulphoxide) which is incubated at 37ºC for 30 min. After 
incubating for 30 min, 0.2 ml of the assay mixture is mixed with 1 ml of the 
kit reagent. Glucose released in the assay mixture is quantified with 
commercial glucose oxidase assay kit (GOD-POD Kit, Agappe 
Diagnostics, Kerala). The enzymatic activity was measured by the amount 
of glucose released, which was detected spectrophotometrically at 505 
nm. The rate of carbohydrate breakdown was determined by calculating 
the amount of glucose obtained when carbohydrate was completely 
digested. The enzyme inhibitory activity was determined as the 
percentage inhibition and the assays were carried out in triplicate & the 
rate of prevention was calculated. The IC50 of the BHFP and BHSP required 
to inhibit the activity of the enzyme by 50% was determined by linear 
regression of the plots with varying concentration of BHFP and BHSP Vs 
percentage inhibition from the three separate tests (Subramanian et al., 
2008; Thalapaneni et al., 2008) 
 
STATISTICAL ANALYSIS: 
          P values are expressed as mean±standard error mean (SEM) 
and analyzed using GraphPad InStat software. 
4.5. IN VITRO ANTIOXIDANT STUDIES 
4.5.1.  DPPH radical scavenging assay (hydrogen donating ability) 
The hydrogen donating ability of BHFP and BHSP were examined in 
the presence of DPPH stable radical. One millilitre of 0.3 mM DPPH ethanol 
solution was added to 2.5 ml of BHFP and BHSP solutions of different 
concentrations in ethanol and allowed to react at room temperature. 
After 30 min the absorbance values were measured at 518 nm. 1.0 ml  
ethanol plus 2.5 ml of BHFP and BHSP solutions were used as a blank. DPPH 
solution (1.0 ml; 0.3 mM) plus ethanol (2.5 ml) was used as negative 
control. The positive controls were those using the standard (Ascorbic 
acid) solutions. Percentage inhibition of DPPH scavenging effect was 
calculated and the IC50 values were determined by linear regression of 
plots with varying concentration of BHFP and BHSP against the 
percentage inhibition from three separate tests (Mensor et al., 2001). 
 
 
4.5.2.  Deoxyribose degradation assay (Hydroxyl radical scavenging 
activity) 
The decomposing effect of BHFP and BHSP on hydroxyl radicals was 
determined by the assay of malondialdehyde chromogen formation due 
to 2-deoxy 2-ribose degradation. The assay mixture contained in a final 
volume of 1ml: 100 μl of 28 mM 2-deoxy 2-ribose dissolved in phosphate 
buffer, pH 7.4, 500 μl of the BHFP and BHSP of various concentrations in 
buffer, 200 μl of 200 mM ferric chloride (1:1 v/v) and 1.04 mM EDTA and 
100 μl of 1.0 mM hydrogen peroxide and 100 μl of 1.0 μM ascorbic acid. 
After incubation of the test sample at 37oC  for 60 min (Fentons system-
generation of hydroxyl radicals). The extent of deoxy ribose degradation 
by the formed hydroxyl radicals was measured directly using thiobarbituric 
acid (TBA) test; 1.0 ml TBA (1%) in 0.05M NaoH) and 1.0 ml 2.8% (w/v) 
trichloroacetic acid were added to the test tubes  and heated at 100 oC  
for 15 min ,cooled and the absorbance was measured at 532 nm against 
the blank containing deoxyribose and buffer solution. The positive controls 
were those using the standard (Quercetin) solutions. Percentage inhibition 
of deoxyribose degradation was calculated and the IC50 values were 
determined by linear regression of plots with varying concentration of 
BHFP and BHSP against the percentage inhibition from three separate tests 
(Gomes et al., 2001) 
4.5.3. NBT reduction assay (Superoxide radical scavenging activity)   
The capacity of the plant extracts to scavenge the superoxide 
anion was assayed by using NBT reduction assay. The superoxide anion 
radical was generated in vitro with hypoxanthine and xanthine oxidase. A 
reaction mixture with a final volume of 3 ml per tube was prepared with 
1.4 ml of 50 mM KH2PO4-KOH  pH 7.4 containing 1 mM EDTA,  0.5 ml of 100 
μm hypoxanthine, 0.5 ml of 100 μM nitro blue tetrazolium (NBT).  The 
reaction was started by adding 0.066 units per tube of xanthine oxidase 
freshly diluted in 100 μl of phosphate buffer and 0.5 ml of BHFP and BHSP in 
saline. The xanthine oxidase was added last. The subsequent rate of NBT 
reduction (measure of superoxide scavenging activity)  was determined 
on the basis of spectrophotometric determinations of absorbance at 560 
nm. Ascorbic acid was used as standard. The results are expressed as the 
percentage inhibition of NBT reduction rate with respect to the reaction 
mixture without test compound (Guzman et al., 2001; Gulcin., 2003). 
4.5.4. Reducing power ability  
Reducing power ability was measured by mixing 1.0 ml BHFP and 
BHSP of varying concentrations (50, 100, 200, 400, 800 µg/ml) in 1 ml of 
distilled water to 2.5 ml of phosphate buffer (0.2 M, pH 6.6) and 2.5 ml of 
1% potassium ferricyanide and incubated at 50°C for 30 min. Later 2.5 ml 
of trichloroacetic acid (10%) were added to the mixture and centrifuged 
at 3000 rpm for 10 min. Finally 2.5 ml from the supernatant were mixed with 
2.5 ml of distilled water and 0.5 ml of 0.1% ferric chloride. The absorbance 
was measured spectrophotometrically at 700 nm. Increased absorbance 
of the reaction mixture indicates increased reducing power. All 
experiments were done in triplicate using butylated hydroxyltoluene (BHT) 
as positive control (Yildrim et al., 2001). 
 
4.6. Determination of % Inhibition  
Percentage antioxidant activity (%AA) was calculated using the formula, 
 
 Where, A0 is the absorbance of the control and A1 is the absorbance of 
the sample. 
4.6.1. Determination of 50% Inhibitory Concentration (IC50) 
The concentration (mg/ml) of the plant extracts required to 
scavenge 50% of the radicals was calculated by using the percentage 
scavenging activities at five different concentrations of the extract. The 
IC50 values were calculated using GraphPad Instat statistical software. 
4.6.2. Statistical analysis 
All determinations were carried out in triplicate and the values are 
expressed as the mean ± SEM. 
 
 
 
 
 
 
 
 
 
5. RESULTS 
5.1. Percentage yield 
The percentage yield of the powder of the fruits of Benincasa hispida 
(Thunb) Cogn was 30% and that of seed powder was 17%. 
5.2 Phytochemical screening  
Preliminary phytochemical screening of the Benincasa hispida fruit and 
seed powders (BHFP and BHSP) are as follows: The BHFP showed the presence 
of triterpenoids, flavonoids, saponins, proteins, tannins and phenolics. 
The preliminary phytochemical screening of BHSP showed the presence of 
flavonoids, alkaloids, saponins, proteins, tannins and phenolics. 
5.3. Inhibition of α amylase in vitro  
Benincasa hispida fruit powder (BHFP) showed α amylase inhibitory 
activity at the varying concentrations tested (50, 100, 200, 400 and 800µg/ml). 
There was a dose dependent increase in the percentage inhibition for all the 
concentrations tested (Table 3). BHFP at a concentration of 50 µg/ml showed a 
percentage inhibition of 8.59, for 100 µg/ml it was 20.42, for 400 µg/ml it was 
increased to 45.66, 800 µg/ml it was 59.68. The IC50 value was found to be 
581.23 µg/ml. 
Benincasa hispida seed powder (BHSP) showed significant α amylase 
inhibitory activity at the varying concentrations tested (50, 100, 200, 400 and 
800µg/ml). There was a dose dependent increase in the percentage inhibition for 
all the concentrations tested (Table 3). BHSP at a concentration of 50 µg/ml 
showed a percentage inhibition of 16.68, for 100 µg/ml it was 30.70, for 400 
µg/ml it was increased to 54.30, 800 µg/ml it was 71.23. The IC50 value was 
found to be 338.66 µg/ml. 
Acarbose was used as the standard drug for the determination of α amylase 
inhibitory activity. The concentration of acarbose is varied (50, 100, 200, 400 and 
800µg/ml). Acarbose at a concentration of 100µg/ml exhibited a percentage 
inhibition of 37.21% and for 800 it was found to be 94.20%. A graded increase in 
the percentage inhibition was observed for the increasing concentrations of the 
drug. The IC50 values of acarbose were found to be 170.80. An increase in the 
IC50 value was observed for the plant extract when compared with the standard 
drug acarbose (Table 3).  
5.4. Inhibition of α glucosidase in vitro                         
The study revealed that BHFP and BHSP had significant α glucosidase 
inhibitory activity at the varying concentrations tested (50, 100, 200, 400, 800 
µg/ml). There was a dose dependent increase in the percentage inhibition for all 
the concentrations tested (Table 4). 
BHFP at a concentration of 50µg/ml showed a percentage inhibition of 
7.71%, at 200µg/ml it was found to be 27.89% and at 800 µg/ml it increased to 
53.42. The IC50 value was found to be 734 µg/ml. 
BHSP at a concentration of 50µg/ml showed a percentage inhibition of 
15.59%, at 200µg/ml it was found to be 36.48% and at 800 µg/ml it increased to 
49.29. The IC50 value was found to be 429 µg/ml. 
Acarbose was used as the standard drug for the determination of α 
glucosidase inhibitory activity. The concentration of acarbose is varied from 50, 
100, 200, 400, 800 µg/ml. Acarbose at a concentration of 100µg/ml exhibited a 
percentage inhibition of 40.73% and for 800 µg/ml it was found to be 72.56%. A 
graded increase in the percentage inhibition was observed for the increasing 
concentrations of the drug. The IC50 values of acarbose were found to be 
202.15µg/ml. An increase in the IC50 values was observed for the plant extract 
when compared with the standard drug acarbose (Table 4). 
5.5. DPPH radical scavenging assay (hydrogen 
donating ability) 
The extracts BHFP and BHSP at various concentrations demonstrated H-
donor activity. The radical scavenging activity of BHFP and BHSP were 
determined from the reduction in the absorbance at 518 nm due to scavenging of 
the stable DPPH free radical. The DPPH scavenging potential for BHFP and 
BHSP varied at varying concentrations (10, 20, 40, 80, 160 µg/ml) and the results 
are shown in Table 5. BHFP and BHSP showed the graded increase in percentage 
of inhibition for all the doses tested and the percentage inhibition ranged from 
9.57% to 57.91%. The IC50 values of BHFP and BHSP were found to be 148.16 
and 130.06 µg/ml respectively. 
Ascorbic acid was used as the reference standard and similar increase in 
the percentage of inhibition was observed for all the concentrations (10, 20, 40, 
80, 160 µg/ml) tested. The DPPH scavenging effect for various extracts was less 
than that of standard compound, ascorbic acid.  The IC50 value of standard was 
found to be 53.04µg/ml. DPPH was reduced with the addition of BHFP and BHSP 
in a concentration dependent manner. 
5.6. Deoxyribose degradation assay (hydroxyl radical scavenging activity) 
Hydroxyl radical scavenging activity was quantified by reaction with 
thiobarbituric acid and the results are shown in the (Table 6). The BHFP and 
BHSP showed 30.12% of activity at 20µg/ml and it was increased to 54.79 % at 
80µg/ml. The IC50 value of BHFP and BHSP were found to be 64.8 and 27 µg/ml 
respectively. Quercetin was used as the reference standard and similar increase in 
the percentage of inhibition was observed for all the concentrations (5, 10, 20, 40, 
80 µg/ml) tested. The IC50 value of quercetin was found to be 18.5 µg/ml. The 
degradation of deoxyribose by Fe3+-ascorbate-EDTA-H2O2 system was markedly 
decreased by BHFP and BHSP tested at various concentrations indicating 
hydroxyl radical scavenging activity.  
5.7. NBT reduction assay (superoxide radical scavenging activity)   
The BHFP and BHSP at various concentrations were found to be a 
scavenger of superoxide anion generated in xanthine oxidase-NBT systems in 
vitro and their activity were comparable to that of ascorbic acid  and the results 
were given in (Table 7). All the concentrations of BHFP and BHSP offered 
greater percentage of inhibition with increase in the concentrations. Ascorbic acid 
was used as the positive control. The IC50 value for BHFP and BHSP were 285 
and 122 µg/ml respectively and that of standard was 39.26 µg/ml. 
5.8. Reducing power ability  
The reductive capabilities of BHFP and BHSP when compared to the 
standard BHT were given in Table 8. The reductive ability of the BHFP and 
BHSP serves as a significant indicator of its antioxidant activity. The reducing 
power of BHFP and BHSP were dose dependent and found to increase with 
increasing concentrations. BHFP and BHSP increased the absorbance up to 0.563 
and 0.394 at 800µg/ml respectively, when the absorbance of the standard at 
800µg/ml was 1.397. All the concentrations of BHFP and BHSP offered higher 
absorbance values than the control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Preliminary phytochemical screening of BHFP  
 
S.No Phytochemical compounds 
Presence 
or 
Absence 
1 Triterpenoids Presence 
2 Flavonoids Presence 
3 Glycosides Absence 
4 Alkaloids Absence 
5 Saponins Presence 
6 Carbohydrates Absence 
7 Proteins Presence 
8 Tannins and 
phenolics 
Presence 
  
 
 
  
 
 
Table 2: Preliminary phytochemical screening of BHSP 
 
S.No Phytochemical compounds 
Presence 
or 
Absence 
1 Triterpenoids Absence 
2 Flavonoids Presence 
3 Glycosides Absence 
4 Alkaloids Presence 
5 Saponins Presence 
6 Carbohydrates Absence 
7 Proteins Presence 
8 Tannins and 
phenolics 
Presence 
 
 
 
 
 
  
 
Table 3: Alpha amylase inhibitory activity of BHFP and BHSP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All determinations were carried out in triplicate manner and values are 
expressed as the mean ± SEM. 
 
 
Sample Concentration (µg/ml) % inhibition IC 50 µg/ml 
BHFP 
50 
100 
200 
400 
800 
8.59 ± 0.54 
20.42 ± 0.53 
30.30 ± 1.80 
45.66 ± 1.11 
59.68 ± 0.93 
581.23 ± 1.557 
BHSP 
50 
100 
200 
400 
800 
16.68 ± 1.40 
30.70 ± 0.98 
41.12 ± 0.46 
54.30 ± 0.52 
71.23 ± 0.97 
338.66 ± 0.881 
Acarbose 
(standard) 
50 
100 
200 
400 
800 
22.77 ± 0.21 
37.21 ± 0.16 
57.49 ± 0.17 
77.98 ± 0.16 
87.70 ± 0.16 
170.80 ± 0.144 
  
Table 4: Alpha glucosidase inhibitory activity of BHFP and BHSP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All determinations were carried out in triplicate manner and values are 
expressed as the mean ± SEM.  
 
 
 
 
Table 5: Hydrogen donating ability of BHFP and BHSP using 
Sample Concentration (µg/ml) % inhibition IC 50 µg/ml 
BHFP 
50 
100 
200 
400 
800 
7.71 ± 0.20 
14.89 ± 0.27 
27.89 ± 0.62 
36.40 ± 0.49 
53.42 ± 0.27 
734 ± 2.082 
BHSP 
50 
100 
200 
400 
800 
15.59 ± 0.13 
28.83 ± 0.14 
36.48 ± 0.34 
49.24 ± 0.35 
61.07 ± 0.34 
429 ± 1.155 
Acarbose  
(standard) 
50 
100 
200 
400 
800 
 
22.77 ± 0.21 
40.73 ± 1.39 
49.34 ± 1.04 
63.48 ± 0.91 
72.56 ± 1.22 
 
202.15 ± 1.021 
DPPH method 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All determinations were carried out in triplicate manner and 
values are expressed as the mean ± SEM. 
 
 
 
 
 
Sample Concentration (µg/ml) % inhibition IC 50 µg/ml 
BHFP 
10 
20 
40 
80 
160 
9.57 ± 0.25 
13.93 ± 0.49 
22.15 ± 0.56 
32.49 ± 0.53 
53.17 ± 0.61 
148.16 ± 0.44 
BHSP 
10 
20 
40 
80 
160 
15.54 ± 0.41 
22.24 ± 0.19 
30.63 ± 0.22 
41.72 ± 0.30 
57.91 ± 0.17 
130.06 ± 0.096 
Ascorbic acid 
(standard) 
10 
20 
40 
80 
160 
 
17.48 ± 0.38 
32.87 ± 1.38 
47.94 ± 0.30 
68.99 ± 0.07 
84.23 ± 0.21 
 
53.04 ± 0.57 
 
Table 6: Scavenging of hydroxyl radical activity by 
BHFP and BHSP using deoxyribose degradation method 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All determinations were carried out in triplicate manner and values are 
expressed as the mean ± SEM. 
Sample Concentration (µg/ml) % inhibition IC 50 µg/ml 
BHFP 
5 
10 
20 
40 
80 
10.25 ± 0.13 
22.23 ± 0.06 
30.12 ± 0.05 
41.72 ± 0.13 
54.79 ± 0.06 
64.80 ± 0.07 
BHSP 
5 
10 
20 
40 
80 
16.26 ± 0.09 
29.13 ± 0.93 
45.10 ± 0.07 
55.61 ± 0.06 
67.87 ± 0.10 
27 ± 1.60 
 
Quercetin   
(standard) 
5 
10 
20 
40 
80 
19.79 ± 0.39 
35.16 ± 0.21 
57.81 ± 0.28 
73.75 ± 0.23 
92.26 ± 0.21 
18.5 ± 0.29 
  
Table 7: Superoxide anion scavenging activity of BHFP AND BHSP using 
NBT reduction assay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All determinations were carried out in triplicate manner and values are 
expressed as the mean ± SEM. 
  
Sample Concentration (µg/ml) % inhibition IC 50 µg/ml 
BHFP 
25 
50 
100 
200 
400 
17.09 ± 0.17 
26.46 ± 0.23 
33.35 ± 0.19 
47.90 ± 0.29 
61.21 ± 0.64 
285 ± 0.0247 
BHSP 
25 
50 
100 
200 
400 
20.22 ± 0.12 
33.66 ± 0.15 
47.74 ± 0.09 
61.67 ± 0.18 
71.07 ± 0.10 
122 ± 0.176 
Ascorbic acid 
(standard) 
25 
50 
100 
200 
400 
33.33 ± 0.03 
63.87 ± 0.45 
76.78 ± 0.21 
85.79 ± 0.17 
91.82 ± 0.14 
39.26 ± 0.54 
 Table 8: Reductive ability of BHFP and BHSP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All determinations were carried out in triplicate manner and values are 
expressed as the mean ± SEM. 
 
 
Sample Concentration (µg/ml) 
Absorbance at 700 nm 
IC 50 µg/ml 
BHFP 
50 
100 
200 
400 
800 
 0.133 ± 0.0002 
0.240 ± 0.0005 
0.318 ± 0.0005 
0.414 ± 0.0020 
0.563 ± 0.0015 
BHSP 
50 
100 
200 
400 
800 
0.081 ± 0.0008 
0.125 ± 0.0023 
0.201 ± 0.0017 
0.279 ± 0.0029 
0.394 ± 0.0011 
BHT          
(standard) 
50 
100 
200 
400 
800 
0.1647 ± 0.001 
0.3252 ± 0.001 
0.5862 ± 0.002 
0.7635 ± 0.003 
1.3972 ± 0.033 
6. DISCUSSION AND CONCLUSION 
Diabetes mellitus is the world’s largest growing metabolic disorder 
of carbohydrate, fat & protein metabolism. A relative or absolute 
deficiency of insulin secretion leads to impaired carbohydrate utilization 
by tissue, which is the characteristic feature of diabetes. 
Alternate strategies to the current modern pharmacotherapy of 
diabetes mellitus are urgently needed because of the inability of existing 
modern therapies to control all the pathological aspects of the disorder, 
as well as the enormous cost and poor availability of the modern 
therapies for many rural populations in developing countries. 
Benincasa hispida (Thunb) Cogn. is used in the folk medicine and 
presumably it has no side effects reported. Since ancient times, people 
trusted on plants and herbs as medicine, as dietary supplements and as 
adjuvant with drugs for better control of diseases and symptoms. 
The present study deals with the exploration of pharmacological and 
phytochemical screening of the selected Indian medicinal plant Benincasa hispida 
(Thunb) Cogn. belonging to the family Cucurbitaceae which is traditionally used 
by the local people and tribals in India for the treatment of asthma, cough, 
diabetes, haemoptysis, hemorrhages from internal organs, epilepsy, fever. The 
fruits and seeds are useful in diabetes (Indian Medicinal Plants, 1985). 
Phytochemical screening of fruit and seed extracts revealed the 
presence of flavonoids and phenolics, accounting for its antidiabetic and 
antioxidant properties. Flavonoids are a group of polyphenolic 
compounds which exhibit several biological effects such as anti-
inflammatory, antihepatotoxic, antiulcer activities, antidiabetic, 
antithrombotic etc. They also inhibit enzymes such as aldose reductase 
and xanthine oxidase. 
The present study was carried out to evaluate the in vitro 
antidiabetic and antioxidant activities of the fruits and seeds of Benincasa 
hispida (Thunb) Cogn. 
The in vitro antidiabetic activity of BHFP and BHSP have been 
evaluated by measuring its α amylase and α glucosidase inhibitory 
activities and was compared with the standard drug acarbose, which is 
specific inhibitor of α glucosidase. Acarbose also possess inhibitory action 
of α amylase. The amount of glucose produced by the action of α 
glucosidase is estimated by using the enzyme glucosidase and peroxidase 
in vitro. The α amylase inhibitory activity of the BHFP is lesser when 
compared to BHSP. However both BHFP and BHSP has lesser inhibition 
percentage than that of the acarbose. However, the α glucosidase 
inhibition of the extract was much lesser than the inhibitory action shown 
by acarbose. The possible mechanism of action of α amylase may be due 
to the blocking of the starch binding site and α glucosidase inhibition may 
be due to blockade of the oligosaccharide binding site. Alpha amylase 
catalyses the hydrolysis of the internal α 1,4 glucosidic linkages in starch 
and other related polysaccharides which has been the targets for the 
suppression of post prandial hyperglycemia. In the light of the result 
present study indicates that BHFP and BHSP both possess antidiabetic 
activity and to be specific the BHSP possess more antidiabetic activity 
than the BHFP. 
Free radicals are known to play a definite role in the pathological 
manifestation of diabetes. Antioxidant fights against free radicals by 
protecting us from various diseases and scavenges the reactive oxygen 
radicals or protects the antioxidant defense mechanism. Reactive oxygen 
species (ROS) are capable of damaging biological macromolecules such 
as DNA, carbohydrates and proteins. ROS is a collective term, which 
includes not only oxygen radicals (O2˙ and OH˙) but also some non-radical 
derivatives of oxygen like H2O2, HOCl, and ozone (O3). In addition, 
antioxidant activity may be regarded as a fundamental property 
important for life. 
The in vitro antioxidant activities of the BHFP and BHSP have been 
evaluated by measuring its scavenging activities by various methods such 
as DPPH radical scavenging assay, deoxyribose degradation assay, NBT 
reduction assay to study the superoxide scavenging activity and reducing 
power ability method to study the total antioxidant capacity. 
DPPH is a stable free radical at room temperature, which produces 
a violet solution in ethanol DPPH is widely used to evaluate the free radical 
scavenging effect of natural antioxidant. DPPH shows a strong absorption 
band at 517 nm in visible spectrum (deep violet colour). As the electron 
becomes paired in the presence of free radical scavenging, the 
absorption vanishes and the resulting discoloration stochiometrically 
coincides with the number of electrons taken up (Mensor et al., 2001). The 
bleaching of DPPH absorption is representative of the capacity of the test 
drugs to scavenge free radicals independently. DPPH radical scavenging 
activities increased with increasing concentrations of BHFP and BHSP. 
Based on the mechanism of reduction of DPPH molecule described in the 
literature, it is correlated with the presence of hydroxyl groups on the 
antioxidant molecule. We can infer that the very good activity of BHFP 
and BHSP was probably due to the presence of substance with an 
available hydroxyl groups. 
Hydroxyl radicals are the highly reactive radicals which are 
produced through the Fenton’s reaction in living system. Hydroxyl radicals 
scavenging activity was quantified by measuring inhibition of the 
degradation of deoxyribose by free radicals (Guzman et al., 2001). 
Deoxyribose levels were determined by reaction with thiobarbituric acid. 
BHFP and BHSP showed a good hydroxyl radical scavenging activity but 
lesser than standard, quercetin. 
Superoxide anion radicals were generated enzymatically in vitro by 
the hypoxanthine and xanthine oxidase system was determined by using 
NBT reduction assay. Superoxide reduces NBT to form a blue coloured 
complex formazone which is measured spectrophotometrically. The 
decrease of absorbance at 560 nm with BHFP and BHSP indicates the 
consumption of superoxide anion in the reaction mixture (Gulcin et al., 
2003). Determination of the mean rate of increase in absorbance over 
one minute period provides a measure of the extent to which the test 
fraction is capable of inhibiting NBT reduction by the superoxide anion 
radical and thus of superoxide scavenging activity.  
The reductive capabilities of BHFP and BHSP were compared with 
BHT. For the measurements of the reductive ability, we investigated the 
Fe3+-Fe2+ transformation in the presence of BHFP and BHSP. The reducing 
capacity of a compound may serve as a significant indicator of its 
potential antioxidant activity. However, the antioxidant activity of 
antioxidants have been attributed to various mechanism, among which 
are prevention of chain initiation, binding of transition metal ion catalysts, 
decomposition of peroxides, prevention of continued hydrogen 
abstraction, reductive capacity and radical scavenging antioxidant 
activity (Gulcin et al., 2004; Amarowiz et al., 2004). The reducing power of 
BHFP and BHSP increased with increasing amount of sample. Here the 
color change occurs from yellow to greenish blue depending upon the 
reducing power of BHFP and BHSP. 
Thus from the present investigation, it can be said that the 
Benincasa hispida (Thunb) Cogn. exhibited remarkable antioxidant 
property in various in vitro assay systems. 
In conclusion, there has been a growing interest in the alternative 
medicine and the therapeutic properties of the natural products derived 
from plants in the recent years. Based on the evaluation done using the 
various in vitro assay models it may be concluded that Benincasa hispida 
(Thunb) Cogn seed extract possess more α amylase and α glucosidase 
enzyme inhibitory actions than the fruit extract and thus retards glucose 
absorption and reduces post prandial hyperglycaemia. The antioxidant 
activity of the plant was proved using various in vitro assay systems. The 
preliminary chemical tests provided insights into the presence of 
polyphenolics compounds in the extract. Hence the above stated 
activities can be attributed due to the presence of these flavonoids. 
Further studies using in vivo models are necessary to confirm these 
activities and to explore the exact mechanism by which the plant 
constituents act. 
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